Wang, Y., Li, N., Zhang, J., Liu, Y., Li, Z., Xu, N., . . . Teng, L. Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: Early results of a phase 2 study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Yan, et al. Efficacy and Safety of Neoadjuvant Sintilimab, Oxaliplatin and Capecitabine in Patients with Locally Advanced, Resectable Gastric or Gastroesophageal Junction Adenocarcinoma: Early Results of a Phase 2 Study. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Yan, et al. Efficacy and Safety of Neoadjuvant Sintilimab, Oxaliplatin and Capecitabine in Patients with Locally Advanced, Resectable Gastric or Gastroesophageal Junction Adenocarcinoma: Early Results of a Phase 2 Study. BMJ Publishing Group.